Support and Resistance Levels
Past performance
About Laurus Labs Ltd Laurus Labs is a leading pharmaceutical and biotechnology company specializing in the development, manufacturing, and sale of generic active pharmaceutical ingredients (APIs) and finished dosage formulations (FDFs). Focused on high-growth therapeutic areas such as anti-retrovirals, Hepatitis C, and Oncology, Laurus Labs operates four manufacturing facilities in Visakhapatnam, India. The company has a strong presence in donor-funded access-to-medicines markets and is expanding its synthesis and nutraceutical/cosmeceutical ingredients businesses.
Established in 2005, Laurus Labs has strategically invested in R&D and manufacturing infrastructure, enabling it to supply APIs to global pharmaceutical companies. Its business lines include Generics - APIs, Generics - FDFs, Synthesis, and Specialty Ingredients. Laurus Labs has launched 59 products and holds 34 patents with 152 pending applications. The company has also expanded through acquisitions, partnerships, and international market entry, including recent ventures into the U.S., EU, and South African markets. Laurus Labs continues to innovate in pharmaceutical manufacturing and specialty chemicals, with ongoing expansions and new facility developments.